Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety of repeat administration of MST-188 during vaso-occlusive crisis of sickle cell disease. Additionally, this study will evaluate the development of a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mast Therapeutics, Inc.
NCT06818266 · Sickle Cell Disease, Acute Chest Syndrome
NCT06477289 · Sickle Cell Disease
NCT06612268 · Sickle Cell Disease
NCT06820515 · Hemophilia, Thrombosis, and more
NCT07392216 · Sickle Cell Disease
Rady Children's Hospital
San Diego, California
Children's Hospital of Southwest Florida
Fort Myers, Florida
Joe Dimaggio Children's Hospital
Hollywood, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions